Literature DB >> 27474751

Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines.

Douglas F Dluzen1, Aimee K Sutliff1, Gang Chen1, Christy J W Watson1, Faoud T Ishmael1, Philip Lazarus2.   

Abstract

The UDP-glucuronosyltransferase (UGT) 2B enzymes are important in the detoxification of a variety of endogenous and exogenous compounds, including many hormones, drugs, and carcinogens. Identifying novel mechanisms governing their expression is important in understanding patient-specific response to drugs and cancer risk factors. In silico prediction algorithm programs were used to screen for microRNAs (miRNAs) as potential regulators of UGT2B enzymes, with miR-216b-5p identified as a potential candidate. Luciferase data suggested the presence of a functional miR-216b-5p binding motif within the 3' untranslated regions of UGTs 2B7, 2B4, and 2B10. Overexpression of miR-216b-5p mimics significantly repressed UGT2B7 (P < 0.001) and UGT2B10 (P = 0.0018) mRNA levels in HuH-7 cells and UGT2B4 (P < 0.001) and UGT2B10 (P = 0.018) mRNA in Hep3B cells. UGT2B7 protein levels were repressed in both HuH-7 and Hep3B cells in the presence of increasing miR-216b-5p concentrations, corresponding with significant (P < 0.001 and P = 0.011, respectively) decreases in glucuronidation activity against the UGT2B7-specific substrate epirubicin. Inhibition of endogenous miR-216b-5p levels significantly increased UGT2B7 mRNA levels in HuH-7 (P = 0.021) and Hep3B (P = 0.0068) cells, and increased epirubicin glucuronidation by 85% (P = 0.057) and 50% (P = 0.012) for HuH-7 and Hep3B cells, respectively. UGT2B4 activity against codeine and UGT2B10 activity against nicotine were significantly decreased in both HuH-7 and Hep3B cells (P < 0.001 and P = 0.0048, and P = 0.017 and P = 0.043, respectively) after overexpression of miR-216b-5p mimic. This is the first evidence that miRNAs regulate UGT 2B7, 2B4, and 2B10 expression, and that miR-216b-5p regulation of UGT2B proteins may be important in regulating the metabolism of UGT2B substrates.
Copyright © 2016 by The Author(s).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27474751      PMCID: PMC5034702          DOI: 10.1124/jpet.116.235044

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  42 in total

1.  Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p.

Authors:  Douglas F Dluzen; Dongxiao Sun; Anna C Salzberg; Nate Jones; Ryan T Bushey; Gavin P Robertson; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2014-01-07       Impact factor: 4.030

Review 2.  UGT genomic diversity: beyond gene duplication.

Authors:  Chantal Guillemette; Eric Lévesque; Mario Harvey; Judith Bellemare; Vincent Menard
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

3.  Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.

Authors:  F Innocenti; L Iyer; J Ramírez; M D Green; M J Ratain
Journal:  Drug Metab Dispos       Date:  2001-05       Impact factor: 3.922

4.  Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.

Authors:  Sumio Ohtsuki; Olaf Schaefer; Hirotaka Kawakami; Tae Inoue; Stephanie Liehner; Asami Saito; Naoki Ishiguro; Wataru Kishimoto; Eva Ludwig-Schwellinger; Thomas Ebner; Tetsuya Terasaki
Journal:  Drug Metab Dispos       Date:  2011-10-12       Impact factor: 3.922

5.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

6.  Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases.

Authors:  Dongxiao Sun; Arun K Sharma; Ryan W Dellinger; Andrea S Blevins-Primeau; Renee M Balliet; Gang Chen; Telih Boyiri; Shantu Amin; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2007-07-30       Impact factor: 3.922

7.  Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.

Authors:  Takeshi Izukawa; Miki Nakajima; Ryoichi Fujiwara; Hiroyuki Yamanaka; Tatsuki Fukami; Masataka Takamiya; Yasuhiro Aoki; Shin-ichi Ikushiro; Toshiyuki Sakaki; Tsuyoshi Yokoi
Journal:  Drug Metab Dispos       Date:  2009-05-13       Impact factor: 3.922

8.  The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.

Authors:  Katriina Itäaho; Peter I Mackenzie; Shin-ichi Ikushiro; John O Miners; Moshe Finel
Journal:  Drug Metab Dispos       Date:  2008-08-21       Impact factor: 3.922

9.  UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.

Authors:  Sarah Chouinard; Olivier Barbier; Alain Bélanger
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  12 in total

1.  MicroRNAs hsa-miR-495-3p and hsa-miR-486-5p suppress basal and rifampicin-induced expression of human sulfotransferase 2A1 (SULT2A1) by facilitating mRNA degradation.

Authors:  Dongying Li; Bridgett Knox; Si Chen; Leihong Wu; William H Tolleson; Zhichao Liu; Dianke Yu; Lei Guo; Weida Tong; Baitang Ning
Journal:  Biochem Pharmacol       Date:  2019-08-22       Impact factor: 5.858

2.  Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.

Authors:  Farideh Shafiee-Kermani; Skyla T Carney; Dereje Jima; Utibe C Utin; LaNeisha B Farrar; Melvin O Oputa; Marcono R Hines; H Karimi Kinyamu; Kevin W Trotter; Trevor K Archer; Cathrine Hoyo; Beverly H Koller; Stephen J Freedland; Delores J Grant
Journal:  Epigenetics       Date:  2020-07-27       Impact factor: 4.528

3.  LINC01578 affects the radiation resistance of lung cancer cells through regulating microRNA-216b-5p/TBL1XR1 axis.

Authors:  Peirong Wang; Linchun Ke; Chuanshu Cai; Feng Dong
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  Anti-Obesity Effect of Bombus ignitus Queen Glycosaminoglycans in Rats on a High-Fat Diet.

Authors:  Mi Young Ahn; Ban Ji Kim; Ha Jeong Kim; Hyung Joo Yoon; Sang Duck Jee; Jae Sam Hwang; Kun-Koo Park
Journal:  Int J Mol Sci       Date:  2017-03-22       Impact factor: 5.923

5.  Analysis of microRNA Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure.

Authors:  Yu Zhao; Yunfei Li; Ling Tong; Xinying Liang; Han Zhang; Lan Li; Guanwei Fan; Yi Wang
Journal:  Front Physiol       Date:  2018-02-06       Impact factor: 4.566

6.  Regulation of UGT2A1 by miR-196a-5p and miR-196b-5p.

Authors:  Aimee K Sutliff; Christy J W Watson; Gang Chen; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2019-03-08       Impact factor: 4.030

7.  Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma.

Authors:  Jun Liu; Wenli Li; Jian Zhang; Zhanzhong Ma; Xiaoyan Wu; Lirui Tang
Journal:  PeerJ       Date:  2019-11-01       Impact factor: 2.984

8.  Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver.

Authors:  Aimee K Sutliff; Jian Shi; Christy J W Watson; Martina S Hunt; Gang Chen; Hao-Jie Zhu; Philip Lazarus
Journal:  Mol Pharmacol       Date:  2019-09-25       Impact factor: 4.436

Review 9.  The Roles of microRNAs in Cancer Multidrug Resistance.

Authors:  Lucia Pavlíková; Mário Šereš; Albert Breier; Zdena Sulová
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639

10.  A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation.

Authors:  Shannon Robin; Khalil Ben Hassine; Tiago Nava; Chakradhara Rao S Uppugunduri; Marc Ansari; Jayaraman Muthukumaran; Simona Jurkovic Mlakar; Maja Krajinovic
Journal:  BMC Mol Cell Biol       Date:  2022-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.